ANDREA RUDOLPH: Open Payments
NPI 1811109986 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$828 in 41 payments from 13 companies in 2025. Trend: 2023 $970 · 2024 $723 · 2025 $828
Food & beverage: $828
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $186 |
| Amgen Inc. | 10 | $138 |
| Alkermes, Inc. | 1 | $129 |
| ABBVIE INC. | 5 | $111 |
| Lilly USA, LLC | 3 | $56 |
| PFIZER INC. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Exact Sciences Corporation | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $29 |
| Eisai Inc. | 1 | $24 |
Products named: LYBALVI, OTEZLA, Wegovy, Ozempic, VRAYLAR, MOUNJARO, UBRELVY, Cologuard Collection Kit.
Industry payments across CA — which companies pay providers there.
